Dalian Holyone Bio-Technology

Dalian Holyone Bio-Technology is a Chinese biotechnology company specializing in the development and large-scale production of recombinant human proteins and diagnostic reagents. Founded in 2005 and based in Dalian, the company is best known for its proprietary yeast-based expression platform used to produce Recombinant Human Serum Albumin (rHSA). This product serves as a safe, animal-free alternative to plasma-derived albumin for use in clinical therapeutics and as a high-grade excipient in the pharmaceutical industry. Holyone's pipeline includes rHSA injections for indications such as hypoalbuminemia and liver cirrhosis, alongside a range of in vitro diagnostic (IVD) kits. The company operates GMP-compliant manufacturing facilities to support its commercial and clinical-stage programs. It is recognized as a key player in the industrialization of recombinant blood products within the Chinese market.